6 results match your criteria: "Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI)[Affiliation]"
Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain.
Lung Cancer
November 2024
Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, Directorate Plan of Oncology, Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI-CERCA), 17004 Girona, Spain; Josep Carreras Leukaemia Research Institute, c/ del sol 15, 17004 Girona, Spain; Department of Medical Sciences, Medical School, University of Girona, Girona, Spain.
Background: Lung cancer (LC) is Europe's primary cause of cancer-related mortality largely due to its historically low survival rates. The aim of this study was to analyze 26-year survival trends in the province of Girona, Spain, and to identify key prognostic factors.
Methods: Population-based study of LC cases collected between 1994 and 2019, with follow-up until December 31, 2021.
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.
Br J Cancer
June 2024
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Article Synopsis
- Menopausal hormone therapy (MHT) may lower the risk of colorectal cancer (CRC), especially in women with a higher genetic predisposition to the disease.
- In a study of nearly 30,000 postmenopausal women, those in the highest genetic risk quartile saw a significantly greater reduction in CRC risk when using MHT compared to those in the lowest quartile.
- The findings suggest that integrating genetic risk information could improve CRC risk predictions and inform the assessment of MHT benefits in postmenopausal women.
Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983-2018.
Front Oncol
July 2023
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI), Girona, Spain.
Background: Hematological neoplasms (HNs) are the first and most common childhood cancers globally. Currently, there is a lack of updated population-based data on the incidence of these cancers in the Spanish pediatric population. This study aimed to describe the incidence and incidence trends of HNs in children (0-14 years) in Spain using data from the Spanish Network of Cancer Registries and to compare the results with other southern European countries.
View Article and Find Full Text PDFIncidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN).
Front Oncol
November 2022
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Introduction: The aim of this study was to describe incidence, incidence trends and survival patterns of lymphoid neoplasms (LNs) and its subtypes in Spain in the period 2002-2013 using data from the Spanish Network of Cancer Registries (REDECAN).
Materials And Methods: Data were extracted from 13 Spanish population-based cancer registries. LNs incident cases were codified using the International Classification of Diseases for Oncology, third edition (ICD-O-3) and grouped according to the WHO 2008 classification.
Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.
J Clin Med
March 2022
Endocrinology and Nutrition Department, Corporació Sanitària Parc Taulí, 8208 Sabadell, Barcelona, Spain.
Article Synopsis
- This study investigates the impact of autism spectrum disorder (ASD) symptoms on psychosocial functioning in adults with Prader-Willi syndrome (PWS), a rare genetic condition.
- Results showed a high prevalence of impaired social responsiveness in the participants, with 76.9% showing difficulties and 50% having significant challenges in social functioning.
- Findings indicate that those with poorer social responsiveness also had lower functionality scores, highlighting the need for evaluations of social skills in patients with PWS during psychosocial assessments.
Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.
Sci Rep
January 2022
CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Comprehensive population-based data on myeloid neoplasms (MNs) are limited, mainly because some subtypes were not recognized as hematological cancers prior to the WHO publication in 2001, and others are too rare to allow robust estimates within regional studies. Herein, we provide incidence data of the whole spectrum of MNs in Spain during 2002-2013 using harmonized data from 13 population-based cancer registries. Cases (n = 17,522) were grouped following the HAEMACARE groupings and 2013-European standardized incidence rates (ASR), incidence trends, and estimates for 2021 were calculated.
View Article and Find Full Text PDF